
CEFTOLON-SB 1.5 GM
MRP: 165
Packaging: 1.5 GM
Pack Type: injection
Composition:
Ceftriaxone Sodium 1000 + Sulbactam 500mg
Indication:
Respiratory Tract Infections, Bacterial Septicemia, Skin & Soft Tissue Infections, Urinary Tract Infections, Meningitis, Pelvic Inflammatory Diseases.
Description:
Ceftriaxone + Sulbactam is a synergistic combination of a broad-spectrum third-generation cephalosporin (Ceftriaxone) with a beta-lactamase inhibitor (Sulbactam). This dual action combats beta-lactamase-producing bacteria that are resistant to cephalosporin monotherapy.
Used to treat:
Lower respiratory tract infections
Urinary tract infections (UTIs)
Intra-abdominal infections
Skin and soft tissue infections
Bone and joint infections
Gynecological infections
Sepsis and surgical prophylaxis
Tags:
- Enhanced efficacy against resistant bacterial strains
- Sulbactam prevents degradation of Ceftriaxone by beta-lactamase
- Once or twice daily dosing
- Effective for both gram-positive and gram-negative infections
- Reduces need for combination therapy
Usage Information
Dosage
Route: Intravenous (IV) or Intramuscular (IM) Adults: 1.5 g once or twice daily depending on severity Children: Dose based on body weight and clinical condition Duration: As prescribed by a physician (typically 5–14 days) Note: Must be administered under medical supervision. Adjust dose in renal impairment.
Side Effects
Common: Local pain/swelling at injection site Nausea, diarrhea Mild rash Elevated liver enzymes Rare/Serious: Hypersensitivity reactions Superinfection (prolonged use) Blood disorders Seizures (especially in renal impairment)
Contraindications
Known allergy to cephalosporins or beta-lactams Severe penicillin hypersensitivity Neonates with hyperbilirubinemia (risk of kernicterus) Concomitant calcium-containing IV solutions in neonates
Availability
Ceftriaxone Sulbactam Injection 1.5g Broad-spectrum antibiotic with beta-lactamase inhibitor Ceftriaxone 1000mg + Sulbactam 500mg IM IV injection for resistant bacterial infections Antibiotic for UTI, RTI, and soft tissue infections
